New publication: Darolutamide Added to Docetaxel Augments Antitumor Effect in Models of Prostate Cancer through Cell Cycle Arrest at the G1-S Transition.

Buck SAJ, Van Hemelryk A, de Ridder C, Stuurman D, Erkens-Schulze S, van ‘t Geloof S, Teubel WJ, Koolen SLW, Martens-Uzunova ES, van Royen ME, de Wit R, Mathijssen RHJ, van Weerden WM.

 

Article link: https://pubmed.ncbi.nlm.nih.gov/38030379/

May 6, 2024